Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

274.59
+12.794.89%
Post-market: 274.590.00000.00%16:10 EST
Volume:290.75K
Turnover:78.35M
Market Cap:7.96B
PE:40.14
High:275.14
Open:261.84
Low:260.73
Close:261.80
52wk High:298.30
52wk Low:122.80
Shares:29.00M
Float Shares:22.98M
Volume Ratio:0.56
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.84
EPS(LYR):6.84
ROE:18.91%
ROA:8.44%
PB:6.53
PE(LYR):40.14

Loading ...

Stock Track | Krystal Biotech Soars 5.06% Intraday on FDA's RMAT Designation for KB707 Lung Cancer Therapy

Stock Track
·
33 mins ago

RMAT Status Puts Krystal Biotech’s KB707 Oncology Ambitions In Focus

Simply Wall St.
·
Yesterday

Krystal Biotech Inc : Chardan Capital Markets Raises Target Price to $323 From $220

THOMSON REUTERS
·
Feb 18

Krystal Biotech Inc : Citigroup Raises Target Price to $371 From $336

THOMSON REUTERS
·
Feb 18

Stock Track | Krystal Biotech Soars 5.99% Intraday on Strong Q4 Earnings Beat

Stock Track
·
Feb 17

Earnings Flash (KRYS) Krystal Biotech Posts Q4 EPS $1.70, vs. FactSet Est of $1.54

MT Newswires Live
·
Feb 17

Krystal Biotech Q4 VYJUVEK revenue rises to USD 107.1 million, up 74% year-on-year

Reuters
·
Feb 17

BRIEF-Krystal Biotech Q4 Net Income USD 51.4 Million

Reuters
·
Feb 17

Krystal Biotech: Q4 EPS $1.70

THOMSON REUTERS
·
Feb 17

Assessing Krystal Biotech (KRYS) Valuation After KB707 RMAT Designation Boosts Oncology Pipeline Prospects

Simply Wall St.
·
Feb 14

Netflix Is Casting a Light on a Rare Disease. Pearl Jam's Frontman Is Raising Cash to Cure It. -- Barrons.com

Dow Jones
·
Feb 14

Krystal Biotech Chief Accounting Officer Kathryn Romano Reports Disposal of Common Shares

Reuters
·
Feb 12

Krystal Biotech Inc. to report financial results and host business update call

Reuters
·
Feb 10

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and Palvella Therapeutics (PVLA)

TIPRANKS
·
Feb 10

FDA Grants RMAT Designation to Krystal Biotech's KB707 for Advanced NSCLC

Reuters
·
Feb 09

Krystal Biotech Announces Rmat Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Feb 09

February 2026's Highlighted Stocks Estimated Below Intrinsic Value

Simply Wall St.
·
Feb 04

US High Growth Tech Stocks To Watch For Potential Gains

Simply Wall St.
·
Jan 28

Krystal Biotech (KRYS) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jan 28

3 Stocks Estimated To Be Trading At Discounts Of Up To 48.8%

Simply Wall St.
·
Jan 21